Expression of CD66 in non‐Hodgkin lymphomas and multiple myeloma
- 11 November 2010
- journal article
- Published by Wiley in European Journal of Haematology
- Vol. 85 (6) , 496-501
Abstract
⁹⁰Y-labeled anti-CD66b monoclonal antibody clone BW 250/183 was developed for treatment of tumors. The aim of the study was the analysis of CD66 expression in lymphoproliferative malignancies to expand the potential of anti-CD66-based therapy. Bone marrow samples from 260 patients were examined for the expression of CD66 on tumor cells in 104 B-chronic lymphocytic leukemias (B-CLL), 28 mantle cell lymphomas (MCL), 22 follicular lymphomas (FCL), 15 marginal zone lymphomas (MZL), 12 lymphoplasmacytic lymphomas (LPL), 13 diffuse large B cell lymphomas (DLBCL), 4 T-non-Hodgkin lymphomas (T-NHL), 3 B-NHL not otherwise specified (B-NHL NOS), 3 B acute lymphoblastic leukemias (B-ALL), and in 56 multiple myelomas (MM) by flow cytometry. Positive (≥ 20%) expression of CD66abce clone Kat4c was detected in 76% of B-CLL and 76.8% of MM. The highest number of CD66abce-positive samples was in MCL and LPL (96.4% of 28 and 91.7% of 12 patients, respectively). Expression of CD66b clone BW 250/183 was examined in 114 of 260 samples. Positive expression was detected in 23.3% of B-CLL (6/35), 17.1% of MM (7/30), and 21.4% of MCL (3/14) samples. The expression of CD66b compared to CD66abce was lower in all measured samples. Use of radiolabeled anti-CD66b antibody for the treatment of lymphoproliferative diseases appears to have limited preclinical substantiation.Keywords
This publication has 23 references indexed in Scilit:
- Radioimmunotherapy with [188Re]-labelled anti-CD66 antibody in the conditioning for allogeneic stem cell transplantation for high-risk acute myeloid leukemiaInternational Journal of Hematology, 2008
- Integration of monoclonal antibodies and immunoconjugates into the treatment of acute myeloid leukemiaCurrent Opinion in Hematology, 2008
- Differential expression of the carcinoembryonic antigen-related cell adhesion molecules panCD66, CD66a, CD66c and of sialyl-Lewis x (CD15s) on blast cells of acute leukemiasInternational Journal of Hematology, 2008
- High expression of CEACAM6 and CEACAM8 mRNA in acute lymphoblastic leukemiasAnnals of Hematology, 2007
- Recent Advances in the Tumour Biology of the GPI-Anchored Carcinoembryonic Antigen Family Members CEACAM5 and CEACAM6Current Oncology, 2007
- CEACAMs: their role in physiology and pathophysiologyCurrent Opinion in Cell Biology, 2006
- Role of CEACAM1 as a Regulator of T CellsAnnals of the New York Academy of Sciences, 2006
- Cellular adhesion molecules as targets for bacterial infectionEuropean Journal of Cell Biology, 2006
- Radioimmunoconjugates in acute leukemia treatment: the future is radiantBone Marrow Transplantation, 2005
- Biliary Glycoprotein mRNA Expression is Increased in Primary Lung Cancer, Especially in Squamous Cell CarcinomaAmerican Journal of Respiratory Cell and Molecular Biology, 1994